Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics

Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in plasma of GBM patients, we performed quantitative comparisons of the plasma proteomes of GBM patients (n = 14) and healthy controls (n...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Miyauchi, Eisuke, Furuta, Takuya, Ohtsuki, Sumio, Tachikawa, Masanori, Uchida, Yasuo, Sabit, Hemragul, Obuchi, Wataru, Baba, Tomoko, Watanabe, Michitoshi, Terasaki, Tetsuya, Nakada, Mitsutoshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841790/
https://ncbi.nlm.nih.gov/pubmed/29513714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193799
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak